|
Site Search
|
Generex Will Test Cancer Vaccine in China
publication date: Oct 9, 2007
Generex Biotechnology Corporation announced it would stage the Phase I trial of its cancer immunotherapy in China. The trial will be performed in collaboration with Dr. Daopei Lu and the Beijing Daopei Hospital in Beijing, China. The immunotherapy demonstrated a robust anti-tumor immunity in a variety of mouse tumor models. More details...
Stock Symbols: (NSDQ: GNBT)
|
Partner Events
October 11-13, 2008
Dalian, China
November 08, 2008
The Institute of Americas, UCSDa
November 9-11, 2008
Shanghai, China
February 23-25, 2009
San Diego
>> More details...
|
